Education
About Us
Working with TipRanks
Follow Us
ABIONYX Pharma SA (FR:ABNX)
:ABNX
ABNX Stock Chart & Stats
€3.89
>-€0.01(-0.63%)
At close: 4:00 PM EST
€3.89
>-€0.01(-0.63%)
Day’s Range― - ―
52-Week Range€1.09 - €5.29
Previous CloseN/A
Volume9.43K
Average Volume (3M)284.77K
Market Cap
€145.17M
Enterprise Value€42.98M
Total Cash (Recent Filing)€3.38M
Total Debt (Recent Filing)€4.12M
Price to Earnings (P/E)―
Beta-0.74
Next Earnings
Mar 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding34,931,010
10 Day Avg. Volume172,880
30 Day Avg. Volume284,772
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)5.40
Price to Sales (P/S)8.72
P/FCF Ratio-11.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ABNX FAQ
What was ABIONYX Pharma SA’s price range in the past 12 months?
ABIONYX Pharma SA lowest stock price was €1.09 and its highest was €5.29 in the past 12 months.
What is ABIONYX Pharma SA’s market cap?
ABIONYX Pharma SA’s market cap is €145.17M.
When is ABIONYX Pharma SA’s upcoming earnings report date?
ABIONYX Pharma SA’s upcoming earnings report date is Mar 17, 2026 which is in 99 days.
How were ABIONYX Pharma SA’s earnings last quarter?
ABIONYX Pharma SA released its earnings results on Sep 25, 2025. The company reported -€0.066 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.066.
Is ABIONYX Pharma SA overvalued?
According to Wall Street analysts ABIONYX Pharma SA’s price is currently Overvalued.
Does ABIONYX Pharma SA pay dividends?
ABIONYX Pharma SA does not currently pay dividends.
What is ABIONYX Pharma SA’s EPS estimate?
ABIONYX Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ABIONYX Pharma SA have?
ABIONYX Pharma SA has 34,931,010 shares outstanding.
What happened to ABIONYX Pharma SA’s price movement after its last earnings report?
ABIONYX Pharma SA reported an EPS of -€0.066 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.049%.
Which hedge fund is a major shareholder of ABIONYX Pharma SA?
Currently, no hedge funds are holding shares in FR:ABNX
Company Description
ABIONYX Pharma SA
ABIONYX Pharma SA (ABNX) is a biopharmaceutical company based in France, focused on the development and commercialization of innovative therapies for cardiovascular and metabolic diseases. The company specializes in the research and production of unique therapeutic products, particularly those involving apolipoproteins and other lipid-based compounds designed to enhance lipid metabolism and improve health outcomes in patients with critical conditions.